Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Here, a suspension HEK293 cell-based AAV production protocol is presented, resulting in reduced time and labor needed for vector production using components that are available for research purposes from commercial vendors.

Abstract

Adeno-associated viral vectors (AAVs) are a remarkable tool for investigating the central nervous system (CNS). Innovative capsids, such as AAV.PHP.eB, demonstrate extensive transduction of the CNS by intravenous injection in mice. To achieve comparable transduction, a 100-fold higher titer (minimally 1 x 1011 genome copies/mouse) is needed compared to direct injection in the CNS parenchyma. In our group, AAV production, including AAV.PHP.eB relies on adherent HEK293T cells and the triple transfection method. Achieving high yields of AAV with adherent cells entails a labor- and material-intensive process. This constraint prompted the development of a protocol for suspension-based cell culture in conical tubes. AAVs generated in adherent cells were compared to the suspension production method. Culture in suspension using transfection reagents Polyethylenimine or TransIt were compared. AAV vectors were purified by iodixanol gradient ultracentrifugation followed by buffer exchange and concentration using a centrifugal filter. With the adherent method, we achieved an average of 2.6 x 1012 genome copies (GC) total, whereas the suspension method and Polyethylenimine yielded 7.7 x 1012 GC in total, and TransIt yielded 2.4 x 1013 GC in total. There is no difference in in vivo transduction efficiency between vectors produced with adherent compared to the suspension cell system. In summary, a suspension HEK293 cell based AAV production protocol is introduced, resulting in a reduced amount of time and labor needed for vector production while achieving 3 to 9 times higher yields using components available from commercial vendors for research purposes.

Introduction

Adeno-associated virus (AAV) was discovered in 1965 and has since been used in a myriad of applications1. AAVs have been applied in neuroscience research to study gene and neuronal function, map neurocircuits, or produce animal models for disease2. Traditionally, this is done by injecting directly at the site of interest, as most natural serotypes do not cross the blood-brain barrier or need a high dose to do so1,2,3.

With the discovery of AAV.PHP.B4 and next-generation capsids....

Protocol

All experimental procedures were approved by the institutional animal care and use committee of the Royal Netherlands Academy of Sciences (KNAW) and were in accordance with the Dutch Law on Animal Experimentation under project number AVD8010020199126. In Figure 1, a schematic overview of the complete protocol is provided. From seeding cells to AAV purification, the protocol takes 6 days to complete.

1. Reagent preparation

  1. Plasmid purif.......

Representative Results

Most academic labs use adherent HEK293T cells for AAV production8,9. While this works relatively well when small amounts of AAV are needed for direct injection, a 100-fold higher titer (minimally 1 x 1011 GC/mouse) is needed to achieve similar transduction with systemic capsids such as AAV.PHP.eB.

In this protocol, the production of AAV using suspension HEK293 cells cultured in conical tubes was established. Small-scale cult.......

Discussion

Systemic administration of AAV is a powerful tool for gene transfer to the CNS; however, the production of AAV is an expensive and laborious process. By using suspension cells, labor and plastics are reduced compared to the adherent culture of HEK293T on 15 cm2 plates. Furthermore, the conical tubes implemented here are easy to handle and maximize the use of laboratory space. The protocol was set up by two researchers and subsequently applied by others in the lab. A series of productions by three independ.......

Acknowledgements

This work was supported by a grant from the Royal Netherlands Academy of Arts and Sciences (KNAW) research fund and a grant from Start2Cure (0-TI-01). We thank Leisha Kopp for her input and advice in the setup of the protocol. Figures were created using Biorender.

....

Materials

NameCompanyCatalog NumberComments
39 mL, Quick-Seal Round-Top Polypropylene Tube, 25 x 89 mm - 50PkBeckman Coulter342414
Adapter 600 mL conical tubes, for rotor S-4x1000, eppendorf5920701002
Adapter Plate fits 16 bioreactors of 600 mlInfors HT/ TPP587633
Aerosol-tight caps, for 750 mL round bucketseppendorf5820747005
Centrifuge 5920 R G, 230 V, 50-60 Hz, incl. rotor S-4x1000, round buckets and adapter 15 mL/50 mL conical tubeseppendorf5948000315
Distilled WaterGibco15230147
DNase I recombinant, RNase-freeRoche4716728001
DNase I recombinant, RNase-freeRoche4716728001
DPBS, calcium, magnesiumGibco14040091
DPBS, no calcium, no magnesiumGibco14190144
Fisherbrand Disposable PES Filter Units 0,2FisherFB12566504
Fisherbrand Disposable PES Filter Units 0,45FisherFB12566505
Holder for 50 ml culture tubes also fits falcon tubeInfors HT/ TPP31362
Holder for 600 ml cell culture tubeInfors HT/ TPP66129
Incubator Minitron 50 mmInfors HT500043
LV-MAX Production MediumGibcoA3583401
N-Tray UniversalInfors HT/ TPP31321
OptiPrep - IodixanolSerumwerk bernburg1893
PEI MAX - Transfection Grade Linear Polyethylenimine Hydrochloride (MW 40,000)Poly-sciences24765-100
Phenol red solution Sigma-Aldrich72420100
Poly(ethylene glycol) 8000Sigma-Aldrich89510
TransIT-VirusGENMirusMir 6706
Trypan Blue Solution, 0.4%Gibco5250061
TubeSpin Bioreactors-50mlTTP87050
TubeSpin Bioreactors-600mlTTP87600
Viral Production CellsGibcoA35347
Vivaspin 20 MWCO 100 000Cytvia28932363

References

  1. Zhou, K., Han, J., Wang, Y., Zhang, Y., Zhu, C. Routes of administration for adeno-associated viruses carrying gene therapies for brain diseases. Front Mol Neurosci. 15, 988914 (2022).
  2. Pietersz, K. L., et al.

Explore More Articles

Adeno associated VirusAAVViral VectorHEK293 CellsSuspension CultureGene TherapyCentral Nervous SystemNeurodegenerative DiseasesMultiple SclerosisParkinson s DiseaseAlzheimer s DiseaseTransfectionPolyethylenimineTransItUltracentrifugationGenome Copies

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved